Meetings reports

MD2: Global development strategy, which market should you go to first?

By 2021-11-23T14:15:00

AdobeStock_449245189

Source: Adobe Stock

Michelle Lotte started the session. She summarised considerations of the MDD/MDR transition against submission to the FDA.

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

 

Not a TOPRA member yet? Join our global community before
30 September and get 3 month’s extra membership for only £20.

Join by 30 September to get this exclusive rate.

Five great reasons to become a TOPRA member:

  1. Great savings on our events and training.
  2. Be part of our dynamic international community.
  3. Contribute to the profession.
  4. Grow your skills and knowledge.
  5. Take your career to the next level.

Become a member today!

Have you heard? Why not listen to one of our free podcasts to see what you’re missing?